Table 2.

Patients’ characteristics.

No.	Sex	Age	Myeloma Type	R-ISS	High-Risk Cytogenetics
1	male	75	IgG kappa	n/a	n/a
2	male	64	IgA kappa	Stage II	yes
3	male	54	IgA kappa	Stage II	no
4	female	56	IgA lambda	Stage II	n/a
5	male	59	kappa	Stage I	no
6	male	48	IgG kappa	Stage I	no
7	female	74	IgG lambda	Stage II	no
8	female	62	IgG kappa	Stage I	no
9	male	63	kappa	Stage III	yes
10	male	47	kappa	Stage II	no
11	male	59	IgG kappa	Stage I	no
12	male	72	IgG lambda	Stage II	no
13	male	61	kappa	Stage II	yes
14	male	68	IgG kappa	Stage II	yes
15	male	61	IgG kappa	Stage I	no
16	female	61	IgG kappa	Stage II	yes
17	male	37	kappa	Stage I	no
18	male	79	IgG kappa	n/a	no
19	male	68	kappa	Stage II	no
20	female	43	IgG lambda	Stage I	no
21	male	46	lambda	Stage II	yes
22	female	44	IgG kappa	Stage II	n/a

n/a = not available; high-risk cytogenetics is defined as t (4;14) and/or t (14;16) and/or del(17p); Ig: Immunoglobulin; R-ISS = Revised International Staging System.